IGC Pharma, Inc. ( IGC) - Key Metrics
IGC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | $0 | -$0.02 | -$0.02 | -$0.02 |
| 2026Q1 | $0 | -$0.02 | -$0.02 | -$0.02 |
| 2025Q4 | $0 | -$0.02 | -$0.01 | -$0.01 |
| 2025Q3 | $0 | -$0.02 | -$0.02 | -$0.02 |
IGC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q2 | ? | -5.18 |
| 2026Q1 | ? | -3.97 |
| 2025Q4 | ? | -4.55 |
| 2025Q3 | ? | -3.57 |
IGC
Price: $0.30
52 week price:
Earnings Per Share: -0.06 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 122069
Market Capitalization: 30.0 million